Multifaceted effects of soluble human CD6 in experimental cancer models.
Inês T SimõesFernando ArandaSergi Casadó-LlombartMaría Velasco-de AndrésCristina CatalàPilar ÁlvarezMarta Consuegra-FernándezMarc Orta-MascaróRamón MerinoJesús MerinoJosé Alberola-IlaGloria González-AseguinolazaEsther CarrerasVanesa MartínezFrancisco LozanoPublished in: Journal for immunotherapy of cancer (2020)
Evidence is provided for the disruption of CD6 receptor-ligand interactions as a feasible immunomodulatory approach in cancer.